BioRestorative Therapies (FRA:9OF) Price-to-Tangible-Book : 0.53 (As of May. 27, 2024)

View and export this data going back to 2021. Start your Free Trial

What is BioRestorative Therapies Price-to-Tangible-Book?

As of today (2024-05-27), BioRestorative Therapies's share price is €1.12. BioRestorative Therapies's Tangible Book per Share of Dec. 2023 for the quarter that ended in Dec. 2023 was €2.11. Hence, BioRestorative Therapies's Price to Tangible Book Ratio of today is 0.53.

The historical rank and industry rank for BioRestorative Therapies's Price-to-Tangible-Book or its related term are showing as below:

FRA:9OF' s Price-to-Tangible-Book Range Over the Past 10 Years
Min: 0.56 Med: 0.73 Max: 0.76
Current: 0.56

During the past 13 years, BioRestorative Therapies's highest Price to Tangible Book Ratio was 0.76. The lowest was 0.56. And the median was 0.73.

FRA:9OF's Price-to-Tangible-Book is ranked better than
93.94% of 1221 companies
in the Biotechnology industry
Industry Median: 2.8 vs FRA:9OF: 0.56

A closely related ratio is called PB Ratio. As of today, BioRestorative Therapies's share price is €1.12. BioRestorative Therapies's Book Value per Sharefor the quarter that ended in Dec. 2023 was €2.25. Hence, BioRestorative Therapies's P/B Ratio of today is 0.50.

BioRestorative Therapies Price-to-Tangible-Book Historical Data

The historical data trend for BioRestorative Therapies's Price-to-Tangible-Book can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

BioRestorative Therapies Price-to-Tangible-Book Chart

BioRestorative Therapies Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Price-to-Tangible-Book

Get a 7-Day Free Trial

0.66

0.63

0.76

BioRestorative Therapies Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Price-to-Tangible-Book	Get a 7-Day Free Trial															0.63	1.02	1.43	0.61	0.76

Competitive Comparison of BioRestorative Therapies's Price-to-Tangible-Book

For the Biotechnology subindustry, BioRestorative Therapies's Price-to-Tangible-Book, along with its competitors' market caps and Price-to-Tangible-Book data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

BioRestorative Therapies's Price-to-Tangible-Book Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, BioRestorative Therapies's Price-to-Tangible-Book distribution charts can be found below:

* The bar in red indicates where BioRestorative Therapies's Price-to-Tangible-Book falls into.

BioRestorative Therapies Price-to-Tangible-Book Calculation

BioRestorative Therapies's price-to-tangible-book ratio for today is calculated as:

Price to Tangible Book	=	Share Price	/	Tangible Book per Share (Q: Dec. 2023 )
	=	1.12	/	2.108
	=	0.53

It can also be calculated from the numbers for the whole company:

Price to Tangible Book	=	Market Cap	/	Tangible Equity
	=	Market Cap	/	(Total Stockholders Equity	-	Preferred Stock	-	Intangible Assets)

A closely related ratio is called PB Ratio. The difference between Price-to-Tangible-Book Ratio and PB Ratio is that book value other than intangibles are used in the calculation.

Be Aware

Some businesses have very light assets, such as software companies or insurance agencies. The Price-to-Book Ratio does not work well for these companies. Some companies even have negative equity, so the Price-to-Book Ratio cannot be applied to them.

BioRestorative Therapies Price-to-Tangible-Book Related Terms

Thank you for viewing the detailed overview of BioRestorative Therapies's Price-to-Tangible-Book provided by GuruFocus.com. Please click on the following links to see related term pages.

BioRestorative Therapies (FRA:9OF) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » BioRestorative Therapies Inc (FRA:9OF) » Definitions » Price-to-Tangible-Book

Comparable Companies

Traded in Other Exchanges

BRTX:USA

Address

40 Marcus Drive, Suite One, Melville, NY, USA, 11747

Website

https://www.biorestorative.com

BioRestorative Therapies Inc is a biotechnology company based in the United States. It focuses on the development of regenerative medicine products and therapies using cell and tissue protocols, primarily involving adult (non-embryonic) stem cells. The company's two core development programs include the Disc/Spine Program, which involves cell therapy candidate, BRTX-100, a product formulated from autologous cultured mesenchymal stem cells collected from the patient's bone marrow; and Metabolic Program, which includes the development of cell-based therapy to target obesity and metabolic disorders using brown adipose-derived stem cells, to generate brown adipose tissue.

BioRestorative Therapies (FRA:9OF) Headlines

No Headlines